DrugPatentWatch Database Preview
Details for Biologics License Application: 125499
» See Plans and Pricing
Summary for BLA: 125499
| Tradename: | PLEGRIDY |
| Applicant: | Biogen Idec Inc |
| Ingredient: | peginterferon beta-1a |
| Patents: | 5 |
| Approval Date: | Aug 15, 2014 |
| Suppliers: see list | 1 |
US Patents for BLA: 125499
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec Inc | PLEGRIDY | peginterferon beta-1a | INJECTABLE;INJECTION | 125499 | 001 | 2014-08-15 | Start Trial | Pathologica LLC (San Francisco, CA) | 2033-01-08 | RX | search | |
| Biogen Idec Inc | PLEGRIDY | peginterferon beta-1a | INJECTABLE;INJECTION | 125499 | 001 | 2014-08-15 | Start Trial | NOVIRA THERAPEUTICS, INC. (Doylestown, PA) | 2034-02-05 | RX | search | |
| Biogen Idec Inc | PLEGRIDY | peginterferon beta-1a | INJECTABLE;INJECTION | 125499 | 001 | 2014-08-15 | Start Trial | Pathologica LLC (San Francisco, CA) | 2033-01-08 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
